The Recipient Contact Information Form 2820 collects contact information on recipients who have agreed to be contacted directly by the CIBMTR for the purpose of inviting them to participate in research activities. If the recipient is a minor, contact information for the parent or legal guardian will be collected. Contact information for an alternate contact is collected if participation in a specific study requires it.

The Form 2820 becomes due in one of two ways.

  1. Pre-Ted Form 2400, “Did the recipient give permission to be directly contacted by CIBMTR for future research”, is answered “yes.”
  2. The patient is enrolled in a clinical trial (e.g. BMT CTN or RCI BMT) that includes a patient reported outcome (PRO) component. When the patient is enrolled the enrollment form triggers Form 2820 to become due.

Only one Form 2820 will become due for any given patient.

The contact information provided in Form 2820 will allow the CIBMTR to contact recipients for the purpose of inviting them to participate in patient reported outcomes (PRO) data collection for the CIBMTR Research Database or other BMT CTN or RCI BMT research studies. To maintain privacy and keep contact information protected, the data provided in Form 2820 is stored in a separate area of the CIBMTR database. Access to these data is highly restricted and governed by CIBMTR policy.

Links to Sections of the Form:
Q1-5: Indication
Q6-21: Recipient Contact Information
Q22-38: Parent / Legal Guardian Contact Information
Q39-58: Alternate Contact Information

Manual Updates
Sections of the Forms Instruction Manual are frequently updated. The most recent updates to the manual can be found below. For additional information, select the manual section and review the updated text.

If you need to reference the historical Manual Change History for this form, please reference the retired manual section on the Retired Forms Manuals webpage.

Date Manual Section Add/Remove/Modify Description
1/21/2021 2820: Recipient Contact Information Modify Instruction text updated: This question should be answered ‘yes’ if the recipient has given permission to be directly contacted by CIBMTR for research as indicated on the Pre-TED F2400 consent tool. This will allow CIBMTR to contact the patient and invite them to participate in PRO data collection or other research studies.
8/2/18 2820: Recipient Contact Information Modify Version 2 of the 2820: Recipient Contact Information section of the Forms Instructions Manual released. Version 2 corresponds to revision 2 of the Form 2820.
Last modified: Jan 21, 2021

Need more help with this?
Don’t hesitate to contact us here.

Was this helpful?

Yes No
You indicated this topic was not helpful to you ...
Could you please leave a comment telling us why? Thank you!
Thanks for your feedback.